We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ODEFSEY emtricitabine (200 mg), rilpivirine (25 mg), tenofovir alafenamide (25 mg) fixed-dose combination tablet (260634)
ARTG ID 260634
ARTG Name
ODEFSEY emtricitabine (200 mg), rilpivirine (25 mg), tenofovir alafenamide (25 mg) fixed-dose combination tablet
Product name
ODEFSEY emtricitabine (200 mg), rilpivirine (25 mg), tenofovir alafenamide (25 mg) fixed-dose combination tablet
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
emtricitabine
rilpivirine hydrochloride
tenofovir alafenamide fumarate
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information